Metabolism, energetics, and lipid biology in the podocyte - Cellular cholesterol mediated glomerular injury

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Chronic kidney disease (CKD) is associated with a high risk of death. Dyslipidemia is commonly observed in patients with CKD and is accompanied by a decrease in plasma high-density lipoprotein (HDL), and an increase in plasma triglyceride-rich lipoproteins and oxidized lipids. The observation that statins may decrease albuminuria but do not stop the progression of CKD indicates that pathways other than the cholesterol synthesis contribute to cholesterol accumulation in the kidneys of patients with CKD.

Original languageEnglish
Article number169
JournalFrontiers in Endocrinology
Volume5
Issue numberSEP
DOIs
StatePublished - Jan 1 2014

Fingerprint

Podocytes
Chronic Renal Insufficiency
Lipid Metabolism
Cholesterol
Wounds and Injuries
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Albuminuria
HDL Lipoproteins
Dyslipidemias
Lipoproteins
Triglycerides
Kidney
Lipids

Keywords

  • ABCA1
  • Apolipoprotein
  • Cholesterol
  • Glomerular disease
  • Kidney disease
  • Nephropathy
  • Podocyte
  • Renal disease
  • Reverse cholesterol transport

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Cite this

Metabolism, energetics, and lipid biology in the podocyte - Cellular cholesterol mediated glomerular injury. / Merscher-gomez, Sandra M; Pedigo, Christopher E.; Mendez, Armando J.

In: Frontiers in Endocrinology, Vol. 5, No. SEP, 169, 01.01.2014.

Research output: Contribution to journalArticle

@article{85e25522749d4ddcb36b96141c5ccea4,
title = "Metabolism, energetics, and lipid biology in the podocyte - Cellular cholesterol mediated glomerular injury",
abstract = "Chronic kidney disease (CKD) is associated with a high risk of death. Dyslipidemia is commonly observed in patients with CKD and is accompanied by a decrease in plasma high-density lipoprotein (HDL), and an increase in plasma triglyceride-rich lipoproteins and oxidized lipids. The observation that statins may decrease albuminuria but do not stop the progression of CKD indicates that pathways other than the cholesterol synthesis contribute to cholesterol accumulation in the kidneys of patients with CKD.",
keywords = "ABCA1, Apolipoprotein, Cholesterol, Glomerular disease, Kidney disease, Nephropathy, Podocyte, Renal disease, Reverse cholesterol transport",
author = "Merscher-gomez, {Sandra M} and Pedigo, {Christopher E.} and Mendez, {Armando J}",
year = "2014",
month = "1",
day = "1",
doi = "10.3389/fendo.2014.00169",
language = "English",
volume = "5",
journal = "Frontiers in Endocrinology",
issn = "1664-2392",
publisher = "Frontiers Media S. A.",
number = "SEP",

}

TY - JOUR

T1 - Metabolism, energetics, and lipid biology in the podocyte - Cellular cholesterol mediated glomerular injury

AU - Merscher-gomez, Sandra M

AU - Pedigo, Christopher E.

AU - Mendez, Armando J

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Chronic kidney disease (CKD) is associated with a high risk of death. Dyslipidemia is commonly observed in patients with CKD and is accompanied by a decrease in plasma high-density lipoprotein (HDL), and an increase in plasma triglyceride-rich lipoproteins and oxidized lipids. The observation that statins may decrease albuminuria but do not stop the progression of CKD indicates that pathways other than the cholesterol synthesis contribute to cholesterol accumulation in the kidneys of patients with CKD.

AB - Chronic kidney disease (CKD) is associated with a high risk of death. Dyslipidemia is commonly observed in patients with CKD and is accompanied by a decrease in plasma high-density lipoprotein (HDL), and an increase in plasma triglyceride-rich lipoproteins and oxidized lipids. The observation that statins may decrease albuminuria but do not stop the progression of CKD indicates that pathways other than the cholesterol synthesis contribute to cholesterol accumulation in the kidneys of patients with CKD.

KW - ABCA1

KW - Apolipoprotein

KW - Cholesterol

KW - Glomerular disease

KW - Kidney disease

KW - Nephropathy

KW - Podocyte

KW - Renal disease

KW - Reverse cholesterol transport

UR - http://www.scopus.com/inward/record.url?scp=84907681499&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907681499&partnerID=8YFLogxK

U2 - 10.3389/fendo.2014.00169

DO - 10.3389/fendo.2014.00169

M3 - Article

AN - SCOPUS:84907681499

VL - 5

JO - Frontiers in Endocrinology

JF - Frontiers in Endocrinology

SN - 1664-2392

IS - SEP

M1 - 169

ER -